On May 23, L-3 Communications Holdings, Inc. (NYSE:LLL) ‘ Unmanned Systems segment has launched its Airborne Pursuit and Exploitation unmanned aircraft system at the Association for Unmanned Vehicle Systems International’s Unmanned Systems 2014 conference held on May 12 to 15. L-3 Communications Holdings, Inc. (NYSE:LLL) net profit margin is 6.20% and weekly performance is 3.89%. On last trading day company shares ended up $118.97. Analysts mean target price for the company is $128.33. L-3 Communications Holdings, Inc. (NYSE:LLL) distance from 50-day simple moving average (SMA50) is 2.77%.
3M Food (NYSE:MMM) Safety announced that its 3M™ Molecular Detection Assay Salmonella has received an extension of the current NF VALIDATION certificate from AFNOR Certification. The extension means that the test kit, which helps food processors and other parties detect Salmonella and consequently prevent salmonellosis, is now validated by the international organization for all human foods and environmental samples. 3M Co (NYSE:MMM) shares fell -0.01% in last trading session and ended the day on $141.43. Gross Margin is 48.20% and its return on assets is 14.10%. 3M Co (NYSE:MMM) quarterly performance is 7.10%.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock, offered at a price to the public of $10.00 per share. The gross proceeds from this offering to BioCryst are expected to be $100 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by BioCryst. BioCryst has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of its common stock. The offering is expected to close on or about June 3, 2014, subject to customary closing conditions. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares moved up 0.80% in last trading session and was closed at $10.07, while trading in range of $9.50 – $10.40. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) year to date (YTD) performance is 32.50 %.
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Agenus Inc. (NASDAQ:AGEN). This pharmaceutical stock has actually seen loss estimates narrowing down over the past month for the current fiscal year. But that is not yet reflected in its price, as the stock lost 13.7% over the same time frame. Agenus Inc (NASDAQ:AGEN) ended the last trading day at $2.86. Company weekly volatility is calculated as 5.47% and price to cash ratio as 6.50. Agenus Inc (NASDAQ:AGEN) showed a positive weekly performance of 8.75%.
On May 22, GTx, Inc. (NASDAQ:GTXI) announced that management will present a company overview on June 4, 2014, at the Jefferies 2014 Global Healthcare Conference in New York City. The GTx presentation will begin at 1:30 pm EST. A simultaneous webcast of the presentation will be accessible from the GTx website at http://www.gtxinc.com. An archived replay of the presentation will be available on the company website until June 18. GTx, Inc. (NASDAQ:GTXI) weekly performance is 17.04%. On last trading day company shares ended up $1.58. Analysts mean target price for the company is $1.50. GTx, Inc. (NASDAQ:GTXI) distance from 50-day simple moving average (SMA50) is 6.01%.
Leave a Reply